Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    Family Hopes to Raise Sanfilippo Syndrome Awareness through #ChaseTheSigns Campaign
    source: pixabay.com

    Family Hopes to Raise Sanfilippo Syndrome Awareness through #ChaseTheSigns Campaign

    When Sophia Scott was growing up, her parents noticed that she was displaying a variety of different potentially concerning traits. They began undergoing some tests. Eventually, just one day before…

    Continue Reading Family Hopes to Raise Sanfilippo Syndrome Awareness through #ChaseTheSigns Campaign
    Jyseleca for Ulcerative Colitis Approved in Scotland for NHS Coverage
    Source: https://unsplash.com/photos/ZHys6xN7sUE

    Jyseleca for Ulcerative Colitis Approved in Scotland for NHS Coverage

      What happens when you treat your condition, but the medication isn’t effective? Sometimes, other approved medications are beneficial for patient use, but other times, there are no approved medications.…

    Continue Reading Jyseleca for Ulcerative Colitis Approved in Scotland for NHS Coverage
    High Rate of Bone Problems in Female Hemophilia Carriers
    https://pixabay.com/en/skeleton-hand-bones-anatomy-joint-778069/

    High Rate of Bone Problems in Female Hemophilia Carriers

    In the past, researchers have observed a relationship between hemophilia and bone-related issues. However, while this observation is helpful, there have been few studies examining the prevalence of bone problems…

    Continue Reading High Rate of Bone Problems in Female Hemophilia Carriers
    ICYMI: EDSIVO for vEDS Earns Breakthrough Therapy Designation
    stevepb / Pixabay

    ICYMI: EDSIVO for vEDS Earns Breakthrough Therapy Designation

    In the United States, the FDA grants Breakthrough Therapy designation to drugs intended to treat serious and life-threatening illnesses, and/or drugs which show significant improvement over available therapies. After receiving…

    Continue Reading ICYMI: EDSIVO for vEDS Earns Breakthrough Therapy Designation
    How Malaria Impacts Your Immune System
    https://pixabay.com/en/mosquito-bug-nature-insect-macro-1652561/

    How Malaria Impacts Your Immune System

    How does our body fight infections? After we get infected with a serious illness, in what ways does our immune system prepare? Understanding these processes could help hone treatments and…

    Continue Reading How Malaria Impacts Your Immune System
    Adolescents with JIA Have Longer Rheumatology Wait Times
    Source: https://pixabay.com/en/boy-man-sitting-thinking-waiting-1149957/

    Adolescents with JIA Have Longer Rheumatology Wait Times

    Adolescence is the phase which exists between childhood and adulthood; therefore, people who are between ages 10-19 are typically considered to be adolescents. How does adolescence change the way people…

    Continue Reading Adolescents with JIA Have Longer Rheumatology Wait Times
    FDA Lifts Clinical Hold on LB-001 IND for Methylmalonic Acidemia
    Source: pixabay.com

    FDA Lifts Clinical Hold on LB-001 IND for Methylmalonic Acidemia

    During the Phase 1/2 SUNRISE clinical trial, which evaluated LB-001 for pediatric patients with methylmalonic acidemia, at least two participants experienced serious and severe adverse reactions: thrombotic microangiopathy. While investigating…

    Continue Reading FDA Lifts Clinical Hold on LB-001 IND for Methylmalonic Acidemia